FAST TRACK GROUP Announces Pricing of $15 Million Initial Public Offering GlobeNewswire May 22, 2025 SINGAPORE, May 22, 2025 (GLOBE NEWSWIRE) — FAST TRACK GROUP (“Fast Track” or the “Company”), a leading entertainment-focused event management and celebrity agency company, announced the pricing of its initial public offering of 3,750,000 ordinary shares (the “Ordinary Shares“) at […]

Expert-led studies will highlight advances across multiple cancer types and examine real-world insights shaping the future of personalized oncology care Clinicians and scientists from RWJBarnabas Health and Rutgers Cancer Institute will share new findings and lead discussions at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, showcasing advances from their cutting-edge cancer research

Sanofi today announces the formal opening of the company's new flagship US offices, unveiling a state-of-the-art modern workplace fostering collaboration and innovation with the ultimate goal of bringing medicines and vaccines to patients faster. New Jersey Governor Phil Murphy and Morristown officials were expected to attend the ribbon-cutting ceremony along with Sanofi CEO Paul Hudson

(NasdaqGM:MRUS), – 63% response rate observed among 43 evaluable patients – 79% overall survival rate at 12-months; 9 months median progression-free survival – Conference Call on Thursday, May 22 at 5:30 p.m. ET UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 22, 2025 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our),

(NASDAQ:WOK), New York, New York, May 22, 2025 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered offering (the “Offering”) for its client WORK Medical Technology Group LTD (Nasdaq: WOK) (the “Company”),

(NASDAQ:KURA),(TSE:4151.T), – Results from KOMET-001 registration-directed trial of ziftomenib in R/R NPM1-m AML patients selected for oral presentation on Monday, June 2nd – – Encore presentation planned at EHA 2025 Congress – – Kura Oncology to host virtual investor event at 7:30pm ET / 4:30pm PT on June 2nd to discuss the trial results –

Merus' Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC GlobeNewswire May 22, 2025 – 63% response rate observed among 43 evaluable patients – 79% overall survival rate at 12-months; 9 months median progression-free survival – Conference Call on Thursday, May 22 at 5:30 p.m. ET UTRECHT, The Netherlands

Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK) GlobeNewswire May 22, 2025 New York, New York, May 22, 2025 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in

Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting GlobeNewswire May 22, 2025 – Results from KOMET-001 registration-directed trial of ziftomenib in R/R NPM1-m AML patients selected for oral presentation on Monday, June 2nd – – Encore presentation planned at EHA 2025 Congress –

This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the “Fund”) with information regarding the sources of the distribution to be paid on May 30, 2025 and cumulative distributions paid fiscal year-to-date. In March 2015, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the